Friday, 22 May 2015
A bipartisan bill was introduced in the Senate to give six more months without generic competition to drugs already on the market in return for approvals for rare diseases, just as a similar measure was approved the same day by a House committee as part of 21st Century Cures legislation.
No comments:
Post a Comment